Home|Journals|Articles by Year|Audio Abstracts
 

Research Article

EEO. 2020; 19(4): 1067-1078


“A CLINICAL STUDY TO EVALUATE THE EFFICACY OF PSORIA-4 Ointment (HYPOTHETICAL) IN THE MANAGEMENT OF MANDAL KUSTHA W.S.R. TO PSORIASIS”

Dr. KOMAL RATHORE, Dr. RAVI SHARMA, Dr. JYOTI GANGWAL.




Abstract

Psoriasis is a proliferative autoimmune skin disease which is affecting 2% of worldwide population. It is
characterized by itching, skin rashes and red scalps with white scales on the skin. Though, different types are
reported, common existing form of psoriasis is plaque psoriasis. The epidemiology of disease seems to be
remains unknown, but the incidence varies, surrounded by the different countries. The samprapti of Mandal
kustha (psoriasis) of the disease appears as drastic cellular changes occur both in epidermis and dermis
which narrates to keratinocyte hyperproliferation.so the treatment should b aimed at vata and kapha shamk
Raktasodhak, varnaya. So in the present study,30 clinicaldiagnosed patients from OPD Of kaya Chikitsa Dept.
At Anusandhan Kendra hospital udaipur were selected along with consideration of inclusion and exclusion
criteria. 30 patient of a group was given PSORIA -4(hypothetical) for locally application 2 month and given
MAHATIKTA ghirit(25ml) Daily with milk .the study revel better result in all parameters and its effectiveness
in controlling the psoriasis.

Key words: Plaque psoriasis, mandal kustha, keratinocyte, Varnya,Rakta sodhak.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.